For weight loss, weight management, and overall wellness, focus on eating healthy foods, like high-protein meals, legumes, ...

Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...

Hims and Hers Health is planning to cash in on Novo Nordisk losing its semaglutide drug exclusivity in Canada. The telehealth ...

U.S. telehealth upstart Hims & Hers Health, Inc. is planning to enter the Canadian market with an eye to selling generic ...

Hims & Hers Health, Inc. (HIMS) announced on Wednesday that it will expand to Canada next year with its weight loss program, ...

NVO submits higher-dose Wegovy to EMA, aiming for greater weight loss and stronger defense against rivals in the obesity ...

Gemma Collins says she was shocked by how her face changed after losing two stone on Mounjaro. Experts warn of a side effect ...

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the company announced ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...